Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080496
Status:
COMPLETED
Last Update Posted:
2008-08-04
First Post:
2004-04-05
Brief Title:
Study Evaluating Tigecycline Versus ImipenemCilastatin in Hospital-Acquired Pneumonia
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Double-Blind Comparative Study Of The Efficacy And Safety Of Tigecycline Vs ImipenemCilastatin For The Treatment Of Subjects With Nosocomial Pneumonia
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the efficacy and safety of the tigecycline regimen with that of the imipenemcilastatin regimen in subjects with nosocomial pneumonia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None